Laura Rufian

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Predictive biomarkers validation of CD3+ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach.

Predictive biomarkers validation of CD3+ cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach.

Journal: Scientific reports
Published: August 26, 2025

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Author Correction: Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Journal: Scientific reports
Published: March 29, 2024

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Journal: Frontiers in immunology
Published: December 04, 2023

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.

Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease.

Journal: Cancers
Published: July 07, 2023

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.

Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges.

Journal: Frontiers in immunology
Published: July 03, 2023

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Journal: Frontiers in immunology
Published: June 20, 2023

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.

Journal: Frontiers in immunology
Published: March 17, 2023

Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.

Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.

Journal: Leukemia
Published: July 31, 2022

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

Journal: Blood advances
Published: May 26, 2022

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA.

Journal: Scientific reports
Published: February 23, 2022

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma.

Pathogenetic and Prognostic Implications of Increased Mitochondrial Content in Multiple Myeloma.

Journal: Cancers
Published: May 26, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026